Over time, there has been inconsistency in both the determination of RhD status of pregnant women, and administration of RhIG. Let’s look at this evolving history and discover how RHD genotyping can ensure more accurate and consistent management of obstetric patients.
READ FULL POST BY Lynsi Rahorst ON THE BLOOD EXPERT BLOG
